19-41303870-C-T

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -14 classification points (ACMG Germline Pathogenicity v2019). BS1BS2BP4_StrongBP6_Moderate

The NM_007040.6(HNRNPUL1):c.1973-102C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.00214 (AC=3,019) in the gnomAD database across 1,408,682 control chromosomes, including 53 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.0253. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★).

Frequency

Genomes: 𝑓 0.0037 ( 9 hom., cov: 32)
Exomes 𝑓: 0.0020 ( 44 hom. )

Consequence

HNRNPUL1
NM_007040.6 intron

Scores

3

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.92

Publications

0 publications found
Variant links:
Genes affected
HNRNPUL1 (HGNC:17011): (heterogeneous nuclear ribonucleoprotein U like 1) This gene encodes a nuclear RNA-binding protein of the heterogeneous nuclear ribonucleoprotein (hnRNP) family. This protein binds specifically to adenovirus early-1B-55kDa oncoprotein. It may play an important role in nucleocytoplasmic RNA transport, and its function is modulated by early-1B-55kDa in adenovirus-infected cells. [provided by RefSeq, Mar 2016]
TGFB1 (HGNC:11766): (transforming growth factor beta 1) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGFB family members. This encoded protein regulates cell proliferation, differentiation and growth, and can modulate expression and activation of other growth factors including interferon gamma and tumor necrosis factor alpha. This gene is frequently upregulated in tumor cells, and mutations in this gene result in Camurati-Engelmann disease. [provided by RefSeq, Aug 2016]
TGFB1 Gene-Disease associations (from GenCC):
  • Camurati-Engelmann disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Camurati-Engelmann disease type 1
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • inflammatory bowel disease, immunodeficiency, and encephalopathy
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • cystic fibrosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_007040.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript

Our verdict: Benign. The variant received -14 points.

BP4
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Strong).
BP6
ClinVar 1-star benign — moderate (BP6); ClinVar germline classification: Benign/Likely Benign, 1 star(s).
BS1
GnomAD effective popmax AF above BS1 threshold — greater than expected for disorder; GnomAD effective popmax AF = 0.0253 vs gene BS1 threshold 0.015.
BS2
≥2 homozygotes in gnomAD — observed in healthy adults (BS2); GnomAD homozygous count = 53.; Very high cumulative gnomAD AC = 3019 (any gene).

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_007040.6. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HNRNPUL1
NM_007040.6
MANE Select
c.1973-102C>T
intron
N/ANP_008971.2
HNRNPUL1
NM_001439168.1
c.1973-102C>T
intron
N/ANP_001426097.1
HNRNPUL1
NM_001439167.1
c.1973-102C>T
intron
N/ANP_001426096.1Q9BUJ2-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HNRNPUL1
ENST00000392006.8
TSL:1 MANE Select
c.1973-102C>T
intron
N/AENSP00000375863.2Q9BUJ2-1
HNRNPUL1
ENST00000602130.5
TSL:1
c.1973-102C>T
intron
N/AENSP00000470687.1Q9BUJ2-2
HNRNPUL1
ENST00000352456.7
TSL:1
c.1673-102C>T
intron
N/AENSP00000340857.3A0A0A0MRA5

Frequencies

GnomAD3 genomes
AF:
0.00360
AC:
548
AN:
152200
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00946
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000519
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000198
Gnomad SAS
AF:
0.0273
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000107
Gnomad OTH
AF:
0.00383
GnomAD4 exome
AF:
0.00195
AC:
2460
AN:
1256364
Hom.:
44
AF XY:
0.00261
AC XY:
1627
AN XY:
622600
show subpopulations
African (AFR)
AF:
0.0116
AC:
328
AN:
28240
American (AMR)
AF:
0.000900
AC:
29
AN:
32416
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19882
East Asian (EAS)
AF:
0.0000458
AC:
2
AN:
38456
South Asian (SAS)
AF:
0.0263
AC:
1844
AN:
70092
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
46132
Middle Eastern (MID)
AF:
0.00438
AC:
21
AN:
4796
European-Non Finnish (NFE)
AF:
0.000107
AC:
97
AN:
963554
Other (OTH)
AF:
0.00264
AC:
139
AN:
52796
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
142
284
425
567
709
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00368
AC:
559
AN:
152318
Hom.:
9
Cov.:
32
AF XY:
0.00388
AC XY:
289
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.00963
AC:
400
AN:
41566
American (AMR)
AF:
0.000519
AC:
8
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000198
AC:
1
AN:
5182
South Asian (SAS)
AF:
0.0280
AC:
135
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000107
AC:
7
AN:
68030
Other (OTH)
AF:
0.00378
AC:
8
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
26
53
79
106
132
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00305
Hom.:
1
Bravo
AF:
0.00331
Asia WGS
AF:
0.00999
AC:
36
AN:
3478

Local populations

ToMMo 61KJPN (+60KJPN MNV)
AF:
0.0000330
AC:
4
AN:
122506
Turkish Variome
AF:
0.00129
AC:
2
AN:
1546
Hom.:
0
WBBC (Westlake BioBank for Chinese) pilot
AF:
0.000112
AC:
1
AN:
8960
Hom.:
0
ABraOM SABE-WGS-1171
AF:
0.00299
AC:
7
AN:
2342
Hom.:
0

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
0.99
DANN
Benign
0.76
PhyloP100
-1.9
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.